Epizyme gets FDA priority review for TAZVERIK in follicular lymphoma
Epizyme has been granted priority review by the US Food and Drug Administration (FDA) for the use of TAZVERIK (tazemetostat) in relapsed or refractory follicular ... Read More
ALX Oncology raises $105m to advance clinical development of ALX148
ALX Oncology, a clinical-stage immuno-oncology company based in California, has raised $105 million in a Series C equity financing round led by Vivo Capital. The ... Read More
ImmunogenX enrolls patients for Solutions for Celiac trial of Latiglutenase
ImmunogenX, a subsidiary of Immunogenics, has started enrollment of patients for a phase 2b clinical trial to evaluate Latiglutenase (IMGX003), its lead candidate for the ... Read More
Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer
Pinpoint Therapeutics, a US biopharma company focused on developing autophagy inhibitors for cancer treatment, has secured $1 million in debt financing led by California-based venture ... Read More
Antios Therapeutics begins phase 1 trial for ATI-2173, a chronic hepatitis B candidate
US biopharma company Antios Therapeutics has initiated its first-in-human phase 1 clinical trial for ATI-2173, a liver-targeted, orally-administered, small molecule against hepatitis B. The phase ... Read More
Australian clinical diagnostics company SpeeDx raises $15m in Series B round
SpeeDx, an Australian clinical diagnostics company, to support improved patient outcomes, has secured $15 million in a Series B funding round from US-based investor Northpond ... Read More
PCI acquires Canadian pharma packaging company Bellwyck Pharma Services
PCI Pharma Services, a pharma supply chain solutions provider, has acquired Canada-based pharma packaging company Bellwyck Pharma Services for an undisclosed price. Bellwyck Pharma Services ... Read More
Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell
Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a technology-focused cell and gene therapy contract development ... Read More
Olympus secures FDA clearance for TJF-Q190V duodenoscope
Olympus Medical Systems Group has secured clearance from the US Food and Drug Administration (FDA) for its TJF-Q190V duodenoscope with a sterile, disposable distal endcap. ... Read More
CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB
CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the removal of anti-platelet agent ticagrelor during surgery ... Read More